TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ERAS

Erasca Inc

Healthcare · Biotechnology

13.90$ -10.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ERAS
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +74.2% +53.5% +218.6% +41.3% +2.0% -18.3%
– +553.3% +945.3% +141.4% +30.4% +2.8% -7.7%
– – -70.6% +536.7% – – –
– +91.9% +134.3% +104.9% -94.8% +113.4% -291.8%
– +6,381.1% -51.2% -12.4% -89.3% +1,171.0% -99.4%
– +240.9% -9.3% +10.0% +28.3% +71.7% –
– – – -23.1% -3.7% +1.3% -9.5%
– +730.1% +213.9% -77.7% -98.7% +18,486.6% -99.5%
– – +717.6% -125.8% – – –
– – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?